Longitudinal Study of People Presenting for First Treatment of a Mood Disorder
Launched by MCMASTER UNIVERSITY · Feb 8, 2012
Trial Information
Current as of April 24, 2025
Unknown status
Keywords
ClinConnect Summary
The proposed study is a prospective naturalistic study of patients with a first treated episode of mania or depression. Patients male or female between the ages of 16 and 50 inclusive with a Mood Disorder according to DSM-IV criteria. Control subjects will also be recruited for this study and undergo the same initial testing. Follow-up visits every second year will be requested of control participants.
Patients will be recruited through Family Physicians, and referrals to the Mood Disorders Program. We will respond to referrals with a brief telephone screening interview, and appropriate re...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Primary Mood Disorder,
- • Age 16-50
- • No previous treatment with psychotropic medication (may have had a max. of 5 days treatment with antidepressants/mood stabilizer \&/or they may have Haldol \&/or Lorazepam for clear restraint)
- Exclusion Criteria:
- • History of CNS illness (except migraines),
- • Thyroid Disease,
- • Neoplastic illness
- • History of, or currently being treated for, Anorexia or Bulimia
- • History of Traumatic Brain Injury
- • Current treatment of Attention-Deficit Hyperactivity Disorder (ADHD)
- • Previous diagnosis of OCD or primary Anxiety disorder
- • Axis-II diagnosis that would suggest non-responsiveness to pharmacotherapy.
- • Substance dependence
Trial Officials
Glenda MacQueen, MD, PhD
Principal Investigator
McMaster University
About Mcmaster University
McMaster University, a leading research institution located in Hamilton, Ontario, Canada, is renowned for its innovative approach to education and its commitment to advancing healthcare through rigorous clinical research. The university's diverse research programs are supported by a multidisciplinary team of experts dedicated to improving patient outcomes and public health. With a strong emphasis on evidence-based medicine, McMaster University actively engages in clinical trials that explore new therapies, interventions, and health technologies, fostering collaboration among researchers, healthcare professionals, and industry partners to translate findings into real-world applications.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Hamilton, Ontario, Canada
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials